Mirae Asset Global Investments Co. Ltd. Buys 336,284 Shares of Intuitive Surgical, Inc. $ISRG

Mirae Asset Global Investments Co. Ltd. purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 336,284 shares of the medical equipment provider’s stock, valued at approximately $136,743,000.

Several other institutional investors have also recently made changes to their positions in ISRG. Beaumont Financial Advisors LLC increased its position in Intuitive Surgical by 3.8% in the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after buying an additional 23 shares in the last quarter. W.G. Shaheen & Associates DBA Whitney & Co raised its stake in Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after buying an additional 25 shares during the period. Blue Fin Capital Inc. raised its stake in Intuitive Surgical by 0.5% during the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after buying an additional 25 shares during the period. Red Spruce Capital LLC raised its stake in Intuitive Surgical by 4.1% during the 2nd quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock worth $255,000 after buying an additional 25 shares during the period. Finally, Worthington Financial Partners LLC boosted its holdings in Intuitive Surgical by 1.3% in the third quarter. Worthington Financial Partners LLC now owns 1,885 shares of the medical equipment provider’s stock worth $767,000 after acquiring an additional 25 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on ISRG shares. Mizuho reduced their price objective on Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating for the company in a research note on Wednesday, October 21st. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Wednesday, October 21st. Stifel Nicolaus cut their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a report on Friday, July 17th. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Finally, HSBC downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target for the company. in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $493.54.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $432.01 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The stock has a market cap of $149.75 billion, a price-to-earnings ratio of 52.24, a PEG ratio of 2.98 and a beta of 1.46. The firm’s 50-day simple moving average is $401.54 and its 200 day simple moving average is $434.05.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.40 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, SVP Patricia Wadors sold 1,078 shares of the company’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the sale, the vice president directly owned 1,026 shares of the company’s stock, valued at $464,993.46. The trade was a 79.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 38,778 shares of company stock valued at $16,814,967 over the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.